Gilead Research Scholars: Solid Tumors
Deadline: March 01, 2022
11 pm
Amount: Up to $130,000 USD (inclusive of any indirect costs), to be paid in annual installments of up to $65,000 USD per year for 2 years.
Purpose
This program is designed to support innovative basic, translational and clinical scientific research related to Oncology Solid Tumors. This may include, but is not limited to, research focused on:
- Agnostic approaches to target solid tumors
- Combinatorial drug strategies/approaches to treatment
- Resistance mechanism identification/novel approaches to addressing resistance mechanisms
- Transformative therapeutic modalities/approaches to treatment
- Patient-specific factors that are predictors of toxicity
- Genomic polymorphisms and impact treatment response
- Novel targets and/or biomarkers
- Novel diagnostic, prevention and treatment strategies
- Research to improve Quality of Life (QoL) / Patient-Reported Outcomes (PROs) e.g. adverse events, addressing unmet needs for patients
- Other basic, translational and clinical research that addresses an unmet medical need or a gap in scientific knowledge
More Info: https://researchscholars.gilead.com/en/solid_tumors_portal/program-overview